TPWA
FLGT icon

Twin Peaks Wealth Advisors’s Fulgent Genetics FLGT Stock Holding History

Twin Peaks Wealth Advisors’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-51
Closed -$1.07K – 856
2025
Q2 		$1.07K Buy
+51
New +$994 ﹤0.01% 1758

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Twin Peaks Wealth Advisors's FLGT Position: Q3 2025 in Review

Twin Peaks Wealth Advisors sold out of Fulgent Genetics (FLGT) in Q3 2025, closing a stake of 51 shares — an estimated $1.07K sold.

Twin Peaks Wealth Advisors first reported a position in FLGT in Q2 2025 and held it in 1 quarter. The position peaked at $1.07K in Q2 2025. 163 funds tracked by Wall St. Rank hold FLGT as of Q3 2025.

  • Twin Peaks Wealth Advisors reported no remaining Fulgent Genetics position as of Q3 2025 after selling out during the quarter.
  • Twin Peaks Wealth Advisors sold 51 Fulgent Genetics shares in Q3 2025, an estimated $1.07K.
  • Twin Peaks Wealth Advisors first reported a position in Fulgent Genetics in Q2 2025 and held it in 1 quarter.
  • Twin Peaks Wealth Advisors's Fulgent Genetics position peaked at $1.07K in Q2 2025.
  • 163 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2025.

Based on Twin Peaks Wealth Advisors's 13F filing for Q3 2025, filed 30 Oct 2025.